| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0952-7915(92)90117-W |
| P698 | PubMed publication ID | 1596364 |
| P2093 | author name string | M. M. Frank | |
| P2860 | cites work | Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins | Q28297889 |
| Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae | Q34563964 | ||
| Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance | Q35587941 | ||
| C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I | Q36349666 | ||
| Genetics of serum resistance in Neisseria gonorrhoeae: the sac-1 genetic locus | Q36446670 | ||
| Complement evasion strategies of microorganisms | Q36705669 | ||
| Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein | Q40155215 | ||
| Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation | Q40162311 | ||
| Inactivation of various proteinase inhibitors and the complement system in human plasma by the 56-kilodalton proteinase from Serratia marcescens | Q40427326 | ||
| Inhibition of complement by culture supernatants of Aspergillus fumigatus. | Q53884721 | ||
| The role of complement and antibody in opsonophagocytosis of type II group B streptococci | Q68878667 | ||
| Antibody-independent killing of gram-negative bacteria via the classical pathway of complement | Q70175013 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | complement system proteins | Q67999591 |
| P304 | page(s) | 14-19 | |
| P577 | publication date | 1992-02-01 | |
| P1433 | published in | Current Opinion in Immunology | Q15752917 |
| P1476 | title | The mechanism by which microorganisms avoid complement attack | |
| P478 | volume | 4 |
| Q47211429 | Antibody-mediated lysis of the bovine subcommissural organ maintained in culture |
| Q47828081 | Biochemical engineering of neural cell surfaces by the synthetic N-propanoyl-substituted neuraminic acid precursor |
| Q39519868 | BrkA protein of Bordetella pertussis inhibits the classical pathway of complement after C1 deposition |
| Q39572622 | Characterization of BrkA expression in Bordetella bronchiseptica. |
| Q34000709 | Characterization of human bactericidal antibodies to Bordetella pertussis. |
| Q40737562 | Complement resistance in microbes |
| Q40737570 | Complement-related proteins in pathogenic organisms |
| Q41404377 | Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement |
| Q34579861 | Factors predisposing to bacterial invasion and infection |
| Q40925056 | Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP). |
| Q36552488 | Humoral response to herpes simplex virus is complement-dependent |
| Q33755319 | Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B-tetanus toxoid vaccine |
| Q28187952 | Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines? |
| Q41344941 | Pneumonia in the surgical patient |
| Q42068191 | Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7. |
| Q72564582 | Schistosoma mansoni circulating anodic antigen but not circulating cathodic antigen interacts with complement component C1q |
| Q80208614 | The mechanisms of activation of normal human serum complement by Escherichia coli strains with K1 surface antigen |
| Q34177433 | The role of bacteriolysis in the pathophysiology of inflammation, infection and post-infectious sequelae |
| Q54496398 | The sensitivity of escherichia coli strains with K1 surface antigen and rods without this antigen to the bactericidal effect of serum. |
Search more.